Is ASPARTATE AMINOTRANSFERASE INCREASED a side effect of glipizide ? ( FactMed.com )

About this FactMed analysis covering adverse side effect reports of glipizide patients who developed ASPARTATE AMINOTRANSFERASE INCREASED.

FactMed provides MD-approved analysis to help both patients, researchers, and physicians accurately assess the risk profile for more than 20,000 different pharmaceutical products. The below report offers compiled information from Food & Drug Administration and FactMed user submissions. Between January 2004 and October 2012, 104 individuals taking glipizide reported ASPARTATE AMINOTRANSFERASE INCREASED to the FDA. A total of 17985 glipizide drug adverse event reaction reports were made with the FDA during this time period. Often the FDA only receives reports of the most critical and severe cases; these numbers may therefore underrepresent the complication rate of the medication.

FDA Research Report

Introduction This page is designed to help you determine the relationship, if any, between glipizide and ASPARTATE AMINOTRANSFERASE INCREASED. In doing so, we compare glipizide with other drugs that cause ASPARTATE AMINOTRANSFERASE INCREASED, to help you evaluate whether or not glipizide causes ASPARTATE AMINOTRANSFERASE INCREASED. Likewise, this page shows the most highly-reported side effects of glipizide, so you can see if ASPARTATE AMINOTRANSFERASE INCREASED ranks among glipizide's most well-known side effects.

Summary Statistics
Reports of glipizide causing ASPARTATE AMINOTRANSFERASE INCREASED: 104
Reports of any side effect of glipizide : 17985
Percentage of glipizide patients where ASPARTATE AMINOTRANSFERASE INCREASED is a reported side effect: 0.5783%

FDA reports of any drug causing ASPARTATE AMINOTRANSFERASE INCREASED : 31671
Average percentage for all medicated patients where ASPARTATE AMINOTRANSFERASE INCREASED is reported as a complication: 0.1985%

Physician opinion on glipizide as adverse event culprit:

Overall opinion for all reports of this drug:

Most frequent diagnoses/indications for prescribing glipizide:

DIABETES MELLITUS ( 2247 patients )
TYPE 2 DIABETES MELLITUS ( 832 patients )
PRODUCT USED FOR UNKNOWN INDICATION ( 588 patients )
DRUG USE FOR UNKNOWN INDICATION ( 569 patients )
DIABETES MELLITUS NON-INSULIN-DEPENDENT ( 137 patients )
ILL-DEFINED DISORDER ( 45 patients )
BLOOD GLUCOSE INCREASED ( 43 patients )
BLOOD GLUCOSE ABNORMAL ( 26 patients )
HYPERGLYCAEMIA ( 14 patients )
TYPE 1 DIABETES MELLITUS ( 11 patients )
ACCIDENTAL POISONING ( 10 patients )
INSULIN-REQUIRING TYPE 2 DIABETES MELLITUS ( 10 patients )
DIABETES MELLITUS INSULIN-DEPENDENT ( 9 patients )
BLOOD GLUCOSE ( 9 patients )
GLUCOSE TOLERANCE IMPAIRED ( 8 patients )
HYPERTENSION ( 6 patients )
MUSCLE SPASMS ( 5 patients )
INSULIN-REQUIRING TYPE II DIABETES MELLITUS ( 4 patients )
RHEUMATOID ARTHRITIS ( 4 patients )
ACCIDENTAL EXPOSURE ( 4 patients )
CARDIAC DISORDER ( 4 patients )
DIABETES MELLITUS INADEQUATE CONTROL ( 3 patients )
DRUG THERAPY ( 3 patients )
TRANSPLANT REJECTION ( 2 patients )
INTENTIONAL OVERDOSE ( 2 patients )
OEDEMA ( 2 patients )
BLOOD GLUCOSE DECREASED ( 2 patients )
RENAL FAILURE ( 2 patients )
COMPLETED SUICIDE ( 2 patients )
DRUG ABUSE ( 1 patients )
PROPHYLAXIS AGAINST TRANSPLANT REJECTION ( 1 patients )
GLYCOSYLATED HAEMOGLOBIN INCREASED ( 1 patients )
BLOOD TRIGLYCERIDES INCREASED ( 1 patients )
CARDIOVASCULAR DISORDER ( 1 patients )
HYPOGLYCAEMIA ( 1 patients )
DEPRESSION ( 1 patients )
DIABETES MELLITUS MANAGEMENT ( 1 patients )
DIABETIC NEUROPATHY ( 1 patients )
PROPHYLAXIS ( 1 patients )
BLOOD PRESSURE ( 1 patients )
SUICIDAL IDEATION ( 1 patients )
HEPATITIS C ( 1 patients )
( 0 patients )

Drugs with high FDA adverse event association with ASPARTATE AMINOTRANSFERASE INCREASED:

ASPIRIN (1980 patients)
TRACLEER (1808 patients)
LIPITOR (1347 patients)
LASIX (1310 patients)
PREDNISOLONE (1261 patients)
CYMBALTA (1231 patients)
ACETAMINOPHEN (1214 patients)
METHOTREXATE (1001 patients)
FUROSEMIDE (863 patients)
ALLOPURINOL (848 patients)
EXJADE (832 patients)
OMEPRAZOLE (830 patients)
ZYPREXA (779 patients)
NORVASC (763 patients)
ARAVA (711 patients)
KETEK (703 patients)
ZOMETA (681 patients)
REMICADE (659 patients)
FOLIC ACID (655 patients)
FAMOTIDINE (613 patients)
LEVOTHYROXINE SODIUM (606 patients)
DIOVAN (600 patients)
PREDNISONE (597 patients)
LISINOPRIL (593 patients)
SEROQUEL (591 patients)
TEGRETOL (591 patients)
GLEEVEC (570 patients)
LANSOPRAZOLE (570 patients)
VOLTAREN (563 patients)
SIMVASTATIN (561 patients)
PREDONINE (552 patients)
COUMADIN (551 patients)
LORAZEPAM (545 patients)
NEXAVAR (543 patients)
ZOCOR (540 patients)
IBUPROFEN (539 patients)
ATENOLOL (537 patients)
NEXIUM (525 patients)
SYNTHROID (509 patients)
CRESTOR (507 patients)
LAMICTAL (504 patients)
ACCUTANE (496 patients)
POTASSIUM CHLORIDE (470 patients)
CYCLOPHOSPHAMIDE (468 patients)
LAMISIL (462 patients)
WARFARIN SODIUM (462 patients)
NEURONTIN (458 patients)
AMBIEN (434 patients)
AMLODIPINE (433 patients)
DIGOXIN (430 patients)
ACYCLOVIR (429 patients)
HYDROCHLOROTHIAZIDE (429 patients)
CLONAZEPAM (427 patients)
PAXIL (421 patients)
CYTARABINE (420 patients)
PLAVIX (416 patients)
ALDACTONE (412 patients)
FOSAMAX (410 patients)
VIOXX (408 patients)
DECADRON (406 patients)
OXYCONTIN (404 patients)
LOXONIN (403 patients)
MAGNESIUM OXIDE (403 patients)
BACTRIM (403 patients)
VANCOMYCIN (398 patients)
DEXAMETHASONE (396 patients)
METFORMIN HCL (394 patients)
MUCOSTA (382 patients)
FLUCONAZOLE (369 patients)
SPIRONOLACTONE (367 patients)
NEORAL (366 patients)
PROTONIX (366 patients)
XANAX (363 patients)
CYCLOSPORINE (363 patients)
RISPERDAL (358 patients)
STRATTERA (357 patients)
ATIVAN (356 patients)
ENBREL (355 patients)
ZETIA (355 patients)
MORPHINE (354 patients)
ALBUTEROL (354 patients)
ZOLOFT (352 patients)
LYRICA (346 patients)
LOVENOX (342 patients)
DEPAKENE (341 patients)
AVONEX (333 patients)
ZOFRAN (331 patients)
ZANTAC (325 patients)
CARBOPLATIN (322 patients)
MYLOTARG (320 patients)
AMARYL (320 patients)
VELCADE (317 patients)
AUGMENTIN '125' (316 patients)
LEVOFLOXACIN (306 patients)
PREDNISONE TAB (305 patients)
SOLU-MEDROL (304 patients)
RIBAVIRIN (303 patients)
CIPROFLOXACIN (299 patients)
LAMIVUDINE (298 patients)
CLOZARIL (291 patients)
SELBEX (289 patients)
VICODIN (288 patients)
PREVACID (281 patients)
RHEUMATREX (281 patients)
URSO 250 (280 patients)
LEXAPRO (277 patients)
DIFLUCAN (275 patients)
OXYCODONE HCL (275 patients)
INSULIN (274 patients)
CISPLATIN (272 patients)
FENTANYL (272 patients)
PEG-INTRON (267 patients)
SINGULAIR (265 patients)
ALLEGRA (261 patients)
PRILOSEC (261 patients)
CLARITHROMYCIN (261 patients)
VITAMIN D (261 patients)
TOPROL-XL (261 patients)
GASTER (260 patients)
MULTI-VITAMINS (260 patients)
LANTUS (258 patients)
CARBAMAZEPINE (257 patients)
MORPHINE SULFATE (255 patients)
REBETOL (253 patients)
ENALAPRIL MALEATE (252 patients)
CELEBREX (252 patients)
RAMIPRIL (252 patients)
AMLODIPINE BESYLATE (252 patients)
GABAPENTIN (251 patients)
ATORVASTATIN CALCIUM (250 patients)
FLUOROURACIL (247 patients)
ZYRTEC (243 patients)
REBIF (242 patients)
REVLIMID (242 patients)
IRESSA (241 patients)
HEPARIN (241 patients)
EFFEXOR (239 patients)
NORVIR (237 patients)
METOPROLOL TARTRATE (237 patients)
PANTOPRAZOLE SODIUM (236 patients)
DIAZEPAM (235 patients)
AMOXICILLIN (233 patients)
PROGRAF (231 patients)
METHYLPREDNISOLONE (230 patients)
PERCOCET (229 patients)
RANITIDINE (229 patients)
AVASTIN (226 patients)
ALPRAZOLAM (224 patients)
PEGASYS (218 patients)
PACLITAXEL (218 patients)
TYLENOL (216 patients)
MULTI-VITAMIN (215 patients)
KALETRA (214 patients)
TRAMADOL HCL (214 patients)
ACTOS (213 patients)
ADVAIR DISKUS 100/50 (212 patients)
KEPPRA (210 patients)
HUMIRA (209 patients)
TRUVADA (208 patients)
TRAZODONE HCL (207 patients)
TAKEPRON (206 patients)
PEPCID (206 patients)
ATARAX (206 patients)
VFEND (205 patients)
CALCIUM (205 patients)
ZOLPIDEM TARTRATE (204 patients)
METFORMIN (202 patients)
VALTREX (202 patients)
TYSABRI (198 patients)
PLATELETS (198 patients)
PURSENNID (197 patients)
BENADRYL (196 patients)
VALPROATE SODIUM (196 patients)
GASMOTIN (196 patients)
GLYBURIDE (195 patients)
PROZAC (195 patients)
KYTRIL (195 patients)
LEVAQUIN (194 patients)
MIRTAZAPINE (193 patients)
COMPAZINE (191 patients)
DEPAS (191 patients)
NITROGLYCERIN (190 patients)
ASCORBIC ACID (188 patients)
ACETYLSALICYLIC ACID SRT (186 patients)
GLUCOPHAGE (185 patients)
DICLOFENAC SODIUM (185 patients)
GEMZAR (184 patients)
TACROLIMUS (183 patients)
ICL670A ICL+DISTAB (182 patients)
VITAMIN E (181 patients)
EPIVIR (180 patients)
NIFEDIPINE (180 patients)
RITONAVIR (180 patients)
SORAFENIB (RAF KINASE INHIBITOR) (179 patients)
AMITRIPTYLINE HCL (178 patients)
ABILIFY (178 patients)
PARACETAMOL (177 patients)
VIREAD (176 patients)
BACLOFEN (176 patients)
ETOPOSIDE (176 patients)
DOXORUBICIN HCL (176 patients)
MEDROL (175 patients)
ZIDOVUDINE (175 patients)
PANTOPRAZOLE (174 patients)
CELEXA (173 patients)
VINCRISTINE (173 patients)
AREDIA (172 patients)
BISOPROLOL FUMARATE (172 patients)
ROCEPHIN (172 patients)
ACTONEL (171 patients)

Most common side effects for patients taking glipizide:

BLOOD GLUCOSE INCREASED (3052 patients)
NAUSEA (2064 patients)
WEIGHT DECREASED (1414 patients)
DYSPNOEA (1145 patients)
VOMITING (1122 patients)
DIZZINESS (1110 patients)
BLOOD GLUCOSE DECREASED (1076 patients)
PAIN (1052 patients)
DIARRHOEA (1045 patients)
ASTHENIA (1038 patients)
FATIGUE (991 patients)
DRUG INEFFECTIVE (976 patients)
CARDIAC FAILURE CONGESTIVE (963 patients)
MYOCARDIAL INFARCTION (895 patients)
DECREASED APPETITE (891 patients)
ANXIETY (764 patients)
HEADACHE (763 patients)
OEDEMA PERIPHERAL (725 patients)
FALL (681 patients)
ANAEMIA (662 patients)
CHEST PAIN (652 patients)
HYPOGLYCAEMIA (620 patients)
RENAL FAILURE (581 patients)
PNEUMONIA (571 patients)
DIABETES MELLITUS (571 patients)
HYPERTENSION (571 patients)
RENAL FAILURE ACUTE (552 patients)
CEREBROVASCULAR ACCIDENT (531 patients)
BACK PAIN (522 patients)
DEPRESSION (519 patients)
PAIN IN EXTREMITY (499 patients)
HYPOTENSION (498 patients)
WEIGHT INCREASED (493 patients)
INJURY (488 patients)
ARTHRALGIA (485 patients)
CORONARY ARTERY DISEASE (481 patients)
CONSTIPATION (473 patients)
PYREXIA (456 patients)
DEATH (455 patients)
TREMOR (454 patients)
DEHYDRATION (449 patients)
ABDOMINAL PAIN (446 patients)
MALAISE (446 patients)
ATRIAL FIBRILLATION (444 patients)
ABDOMINAL PAIN UPPER (414 patients)
COUGH (414 patients)
FEELING ABNORMAL (405 patients)
HYPERHIDROSIS (398 patients)
INSOMNIA (397 patients)
PRURITUS (396 patients)
CONFUSIONAL STATE (372 patients)
URINARY TRACT INFECTION (372 patients)
GAIT DISTURBANCE (357 patients)
RASH (356 patients)
EMOTIONAL DISTRESS (332 patients)
DIABETES MELLITUS INADEQUATE CONTROL (313 patients)
PANCREATITIS (312 patients)
GASTROOESOPHAGEAL REFLUX DISEASE (306 patients)
HYPOAESTHESIA (305 patients)
DYSPEPSIA (302 patients)
FLUSHING (301 patients)
TYPE 2 DIABETES MELLITUS (300 patients)
ANHEDONIA (295 patients)
SEPSIS (285 patients)
SYNCOPE (285 patients)
VISION BLURRED (281 patients)
SOMNOLENCE (281 patients)
MYALGIA (277 patients)
LOSS OF CONSCIOUSNESS (273 patients)
MUSCLE SPASMS (272 patients)
PLEURAL EFFUSION (272 patients)
DRUG EFFECT DECREASED (271 patients)
CARDIAC DISORDER (268 patients)
BLOOD CREATININE INCREASED (266 patients)
ABDOMINAL DISTENSION (264 patients)
HAEMOGLOBIN DECREASED (262 patients)
CONDITION AGGRAVATED (256 patients)
PALPITATIONS (256 patients)
INJECTION SITE PAIN (255 patients)
CONVULSION (254 patients)
PARAESTHESIA (252 patients)
BLOOD PRESSURE INCREASED (244 patients)
CHRONIC OBSTRUCTIVE PULMONARY DISEASE (242 patients)
DRUG INTERACTION (238 patients)
DYSPHAGIA (238 patients)
MENTAL STATUS CHANGES (238 patients)
MUSCULAR WEAKNESS (229 patients)
HYPERGLYCAEMIA (228 patients)
RESPIRATORY FAILURE (225 patients)
MITRAL VALVE INCOMPETENCE (224 patients)
ERYTHEMA (223 patients)
UNEVALUABLE EVENT (222 patients)
NEUROPATHY PERIPHERAL (219 patients)
CHILLS (218 patients)
CARDIAC ARREST (217 patients)
OEDEMA (213 patients)
INCORRECT DOSE ADMINISTERED (212 patients)
BRONCHITIS (205 patients)
OSTEOARTHRITIS (202 patients)
BLOOD GLUCOSE FLUCTUATION (202 patients)
HYPERLIPIDAEMIA (202 patients)
ECONOMIC PROBLEM (200 patients)
BALANCE DISORDER (199 patients)
CELLULITIS (198 patients)
CONTUSION (197 patients)
OSTEONECROSIS OF JAW (196 patients)
ACUTE MYOCARDIAL INFARCTION (196 patients)
ABDOMINAL DISCOMFORT (195 patients)
NERVOUSNESS (189 patients)
HYPERKALAEMIA (188 patients)
GLYCOSYLATED HAEMOGLOBIN INCREASED (186 patients)
PHARMACEUTICAL PRODUCT COMPLAINT (186 patients)
STRESS (185 patients)
HYPERSENSITIVITY (183 patients)
INFECTION (182 patients)
RENAL FAILURE CHRONIC (182 patients)
COMPLETED SUICIDE (180 patients)
BLOOD CHOLESTEROL INCREASED (179 patients)
ANOREXIA (178 patients)
THROMBOCYTOPENIA (173 patients)
GASTROINTESTINAL HAEMORRHAGE (173 patients)
SINUSITIS (172 patients)
HEART RATE INCREASED (172 patients)
CARDIOMEGALY (171 patients)
DEEP VEIN THROMBOSIS (168 patients)
LETHARGY (167 patients)
TRANSIENT ISCHAEMIC ATTACK (166 patients)
FLATULENCE (166 patients)
INTERNATIONAL NORMALISED RATIO INCREASED (165 patients)
MEMORY IMPAIRMENT (163 patients)
RENAL IMPAIRMENT (160 patients)
HYPOKALAEMIA (160 patients)
PANCYTOPENIA (158 patients)
FEAR (158 patients)
MULTI-ORGAN FAILURE (157 patients)
MEDICATION ERROR (155 patients)
PULMONARY EMBOLISM (155 patients)
CARDIO-RESPIRATORY ARREST (155 patients)
ARRHYTHMIA (154 patients)
CHOLELITHIASIS (154 patients)
ATELECTASIS (154 patients)
GENERAL PHYSICAL HEALTH DETERIORATION (153 patients)
ARTHRITIS (153 patients)
TREATMENT NONCOMPLIANCE (149 patients)
CORONARY ARTERY OCCLUSION (149 patients)
CHEST DISCOMFORT (148 patients)
VISUAL ACUITY REDUCED (148 patients)
GASTRITIS (148 patients)
DYSGEUSIA (147 patients)
DIABETIC NEUROPATHY (147 patients)
NASOPHARYNGITIS (144 patients)
INJECTION SITE HAEMORRHAGE (143 patients)
INJECTION SITE BRUISING (143 patients)
FLUID RETENTION (143 patients)
SINUS TACHYCARDIA (143 patients)
BRADYCARDIA (142 patients)
MUSCULOSKELETAL PAIN (142 patients)
RECTAL HAEMORRHAGE (142 patients)
OSTEOMYELITIS (141 patients)
HAEMATURIA (140 patients)
DYSPNOEA EXERTIONAL (140 patients)
FEELING HOT (139 patients)
RENAL INJURY (138 patients)
BLOOD UREA INCREASED (138 patients)
RENAL DISORDER (137 patients)
HYPONATRAEMIA (137 patients)
OVERDOSE (136 patients)
PULMONARY OEDEMA (136 patients)
MYOCARDIAL ISCHAEMIA (136 patients)
URTICARIA (136 patients)
TRICUSPID VALVE INCOMPETENCE (135 patients)
JOINT SWELLING (134 patients)
PLATELET COUNT DECREASED (134 patients)
CARDIOMYOPATHY (134 patients)
THROMBOSIS (132 patients)
HYPOPHAGIA (130 patients)
PULMONARY HYPERTENSION (130 patients)
DEFORMITY (130 patients)
PANCREATITIS ACUTE (128 patients)
ANGINA PECTORIS (127 patients)
NECK PAIN (126 patients)
SWELLING (126 patients)
ASTHMA (125 patients)
SPINAL OSTEOARTHRITIS (125 patients)
ERECTILE DYSFUNCTION (125 patients)
VISUAL IMPAIRMENT (124 patients)
DRY MOUTH (124 patients)
RHINORRHOEA (123 patients)
EPISTAXIS (122 patients)
FEELING JITTERY (120 patients)
TOOTH EXTRACTION (117 patients)
CARDIAC FAILURE (117 patients)
ALANINE AMINOTRANSFERASE INCREASED (117 patients)
RHABDOMYOLYSIS (117 patients)
ERUCTATION (117 patients)
SWELLING FACE (117 patients)
OFF LABEL USE (116 patients)
BLOOD GLUCOSE ABNORMAL (116 patients)
PERIPHERAL VASCULAR DISORDER (115 patients)
DYSURIA (115 patients)
POLLAKIURIA (115 patients)
MULTIPLE INJURIES (115 patients)
LUNG INFILTRATION (114 patients)
BLOOD PRESSURE DECREASED (114 patients)
NEPHROLITHIASIS (114 patients)
CATARACT (113 patients)
HYPOXIA (112 patients)
HAEMATOCHEZIA (111 patients)
EXOSTOSIS (111 patients)
HAEMATOCRIT DECREASED (111 patients)

In addition to reviewing our up-to-date FDA research, users may interact with the FactMed community - currently one million members and growing! FactMed online research and discussions are read by patients, scientists, physicians, and other interested health care parties. Post follow up Questions to learn from our diverse readership. Likewise, patients who have experienced unwanted effects are encouraged to share their Concerns to help educate and inform our members.

Recent FactMed Activity for glipizide

Issue	Description / Topic	Timestamp
QUESTION BACTERIAL SEPSIS	E para que serve este medicamento	2015-04-01 22:31:30
QUESTION PLATELET COUNT INCREASED	I have been taking glipizide for a year now and my last blood work showed elevated platelet count. My RBC and WBC are in the normal range though. My doctor suspects the glipizide causes stress in my body when I get hypoglycemic so my body is fighting it. Does anyone think this could be true?	2015-04-09 12:17:27
QUESTION HEPATORENAL SYNDROME	My sister is in hepatorenal failure. Her A1c is 5, blood sugars running 200 to 300. Doctor put her back on glipizide, is this going to exacerbate hepatorenal failure.	2015-04-29 22:55:19
QUESTION EYE PAIN	Ways of dealing with eye pain?	2015-06-20 20:08:32
QUESTION URINE FLOW DECREASED	Since taking glipizide I seem to be gaining weight and I am not urinating as frequently as prior to taking the medication and my urine flow at times seems to be getting weaker	2015-08-01 15:54:42
QUESTION HEPATITIS C	I have recently beend diagnosed and treated successfully for HepC. Will Glipizide put me at risk for a re-occurence?	2016-01-03 14:19:54
QUESTION BLOOD AMINO ACID LEVEL DECREASED	I am on Glipizide 5 mg oral for type 2 diabetic condition. I have 2 or more soft stools per day now. Lopermide not working vey well an suggestions?	2016-01-18 13:53:55
QUESTION EXPIRED DRUG ADMINISTERED	My glipizide is expired by a month will it still work if I take it	2016-02-14 22:57:07
QUESTION WEIGHT INCREASED	How many times a day y Should you take this pill	2016-03-01 19:35:19
QUESTION COUGH	Is coughing, like a dry cough a side effect from takim glipizide	2016-05-15 18:10:40
QUESTION GLOMERULAR FILTRATION RATE DECREASED	On 2.5mg glipizide doing great but Nephrologist doubled dose to 5mg, in one month my gfr dropped to 22 from 24 where it had been stable for six months. My glucose did NOT change. Could the glipizide increase cause the gfr to drop like this ? I have many other medical issues.	2016-06-22 15:38:09
QUESTION PANIC ATTACK	I've eliminated everything but glipizide. Has to be the culprit of panic attacks for last 5 months	2016-08-01 18:34:29
QUESTION KIDNEY INFECTION	Can glipizide cause kidney infection	2016-09-07 19:44:42
QUESTION PLATELET COUNT INCREASED	I have been taking glipizide for 18 months and now have a high platelet count, is there any connection?	2016-10-17 14:49:49
QUESTION ACNE	I stopped taking my gemfribozil as advised by my doctor because of something that looks like acne and hurts. I noticed It began around the bottom and behind my ears. I have been off the med for almost a week but I suspect the glipizide I did read up on gemfribozil and it causes rash , is there issues with gemfribozil too ?	2016-11-06 09:51:30
QUESTION PLATELET COUNT ABNORMAL	Have been taking Glipizide for 3 years, low platelet count was 109, doctor took me off glipizide would that cause low platelet?	2017-02-27 21:14:39
QUESTION PLATELET COUNT ABNORMAL	Have been taking Glipizide for 3 years, low platelet count was 109, doctor took me off glipizide would that cause low platelet?	2017-02-27 21:16:17
QUESTION LYMPHOMA	My husband has been on glipizide ,for his type 2 diabetes,for about two years.he also had a MRI in January to evaluate his spinal stenosis and sciatica pain.from this MRI,he had an incidental finding of small cell b lymphoma at the sacrum level.he has no symptoms of lymphoma.could the glipizide be a contributing factor to the lymphoma.	2017-05-02 12:37:28
QUESTION WHEELCHAIR USER	x64e3yvzoxlukr03gl	2017-06-19 03:21:12

My Patient Resources

Get your questions answered! Over one million patients, researchers, and health care providers have visited FactMed. If you have a question about ASPARTATE AMINOTRANSFERASE INCREASED and glipizide, post it here. You may receive a response from a fellow patient - or a leading expert in the field.

Your Question:

Share your experience: Over one million patients, researchers, and health care providers have visited FactMed. If you have a noteworthy experience as a patient taking glipizide, post it here. Your story could help a fellow patient - or provide insight to a leading expert in the field.

Your Experience or Concern:

Telemedicine Expert Consults FactMed newest feature allows patients to consult - via realtime videoconferencing - experts in glipizide. This premium feature connects patients to experts, regardless of geography. FactMed experts charge reasonable rates that may be reimbursable by your insurance as a second-opinion.

We are currently accepting registration for glipizide experts. If you are a healthcare provider experienced in prescribing glipizide, please register here.